ESLA
Estrella Immunopharma Inc.
0.471$
-0.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | +203.8% | +652.4% | -60.7% | +56.0% | +59.9% | |
| – | +7.2% | +123.9% | +382.7% | -23.9% | +15.5% | |
| – | +129.7% | +559.5% | -34.2% | +21.0% | +47.7% | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – | |
| – | – | – | – | – | -50.4% | |
| – | – | – | – | – | – | |
| – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.